Supplementary Table S1 from Proteomic Signatures of Epidermal Growth Factor Receptor and Survival Signal Pathways Correspond to Gefitinib Sensitivity in Head and Neck Cancer

Authors :: Zhong Chen
Carter Van Waes
Katherine R. Calvo
John C. Morris
Xiaojiang Xu
Gerhard S. Mundinger
Kunal Saigal
Bhavana Dabir
Jay Friedman
Bin Yan
Mary E. Winters
Clint T. Allen
Francisco G. Pernas
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Supplementary Table S1 from Proteomic Signatures of Epidermal Growth Factor Receptor and Survival Signal Pathways Correspond to Gefitinib Sensitivity in Head and Neck Cancer

Tools